文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

氯化米库氯铵与琥珀胆碱用于支气管镜检的效果与安全性:单中心、随机、非劣效、阳性对照临床试验的研究方案

Effect and safety of mivacurium chloride and succinylcholine for bronchoscopy: study protocol for a single-center, randomized, non-inferiority, and positive-controlled clinical trial.
PubMed 文献 · Trials · 2026-01-22

这是一项前瞻性、单中心、随机、评估者盲法、阳性对照试验,旨在评估氯化米库氯铵相比琥珀胆碱在软性支气管镜检中肌肉松弛效果与安全性的非劣效性。主要终点为停用肌松药后15分钟内自主呼吸恢复率,其他结局包括不同恢复水平时间、血流动力学变化、不良事件及医患满意度。试验注册于中国临床试验注册中心(ChiCTR2400091276,2024年10月23日)和ClinicalTrials.gov(NCT06709066,2024年11月29日)。

要点

  • 研究假设氯化米库氯铵在恢复时间上非劣于琥珀胆碱,在安全性和舒适度上更优。
  • 主要终点为停用肌松药后15分钟内自主呼吸恢复率。
  • 试验为前瞻性、单中心、随机、评估者盲法、阳性对照设计。

原文

BACKGROUND: Succinylcholine is favored for its rapid onset and offset, but its use is limited by adverse effects. Mivacurium chloride, a non-depolarizing relaxant, offers a similar shorter duration and fewer cardiovascular effects, especially without worrying about muscle pain and hyperkalemia, making it a potential alternative in some short-time operations. This study aims to assess the non-inferiority of mivacurium chloride compared to succinylcholine in terms of muscle relaxation effect and safety during flexible bronchoscopy. METHODS: This is a prospective, single-center, randomized, assessor-blinded, positive-controlled trial. Participants scheduled for flexible bronchoscopy requiring muscle relaxation were randomly assigned to receive either mivacurium chloride or succinylcholine. The primary endpoint is the recovery rate of spontaneous breathing within 15 min after discontinuation of muscle relaxants. Other outcomes, including recovery time at different levels, hemodynamic changes, adverse events, and satisfaction from physicians and patients, are also collected. DISCUSSION: This study aims to compare the recovery effect of mivacurium chloride for muscle relaxation during bronchoscopy with succinylcholine, hypothesizing that mivacurium chloride is non-inferior in recovery time and superior in safety and comfort. TRIALS REGISTRATION: Chinese Clinical Trial Registry ChiCTR2400091276. Registered on 23 October 2024. CLINICALTRIALS: gov NCT06709066. Posted on 29 November 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Zhang X, Xu Y, Li J, et al. Effect and safety of mivacurium chloride and succinylcholine for bronchoscopy: study protocol for a single-center, randomized, non-inferiority, and positive-controlled clinical trial. Trials. 2026. PMID: 41566470. doi:10.1186/s13063-026-09463-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。